'''Bemesetron''' ('''MDL-72222''') is a [[drug]] which acts as an [[Antagonist (pharmacology)|antagonist]] at the [[5-HT3 receptor|5HT<sub>3</sub>]] [[Receptor (biochemistry)|receptor]].<ref>{{cite journal |vauthors=Shearman GT, Tolcsvai L |title=Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists |journal=Psychopharmacology |volume=92 |issue=4 |pages=520–3 |year=1987 |pmid=3114804 |doi=10.1007/bf00176488}}</ref> It has [[antiemetic]] effects comparable to [[metoclopramide]],<ref>{{cite journal |vauthors=Homesley HD, Hahne WF, McLees B |title=Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen |journal=Am. J. Clin. Oncol. |volume=16 |issue=2 |pages=175–9 |date=April 1993 |pmid=8452114 |doi=10.1097/00000421-199304000-00020|display-authors=etal}}</ref> however it is not used clinically, instead its main application is in scientific research studying the involvement of the 5HT<sub>3</sub> receptor in the actions of drugs of abuse.<ref>{{cite journal |vauthors=McKinzie DL, McBride WJ, Murphy JM, Lumeng L, Li TK |title=Effects of MDL 72222, a serotonin3 antagonist, on operant responding for ethanol by alcohol-preferring P rats |journal=Alcohol. Clin. Exp. Res. |volume=24 |issue=10 |pages=1500–4 |date=October 2000 |pmid=11045857 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0145-6008&volume=24&issue=10&spage=1500 |doi=10.1111/j.1530-0277.2000.tb04567.x}}</ref><ref>{{cite journal |vauthors=Kankaanpää A, Meririnne E, Seppälä T |title=5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat |journal=Psychopharmacology |volume=159 |issue=4 |pages=341–50 |date=February 2002 |pmid=11823886 |doi=10.1007/s00213-001-0939-4}}</ref><ref>{{cite journal |vauthors=Kos T, Popik P, Pietraszek M |title=Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice |journal=Eur Neuropsychopharmacol |volume=16 |issue=4 |pages=297–310 |date=May 2006 |pmid=16288851 |doi=10.1016/j.euroneuro.2005.10.001 |url=http://linkinghub.elsevier.com/retrieve/pii/S0924-977X(05)00146-X|display-authors=etal}}</ref><ref>{{cite journal |vauthors=Yoo JH, Nam YS, Lee SY, Jang CG |title=Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice |journal=Synapse |volume=62 |issue=1 |pages=8–13 |date=January 2008 |pmid=17948891 |doi=10.1002/syn.20461}}</ref>
